Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (91-100 of 292) with videos related to

Pageof 30
Sort By:
Heart (British Cardiac Society)|January 24, 2013
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathyConstantinos O'Mahony, Maite Tome-Esteban, Pier D Lambiase, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 23, 2023
Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-makingGabrielle Norrish, Alexandros Protonotarios, Maria Stec, et al.
Journal of the American College of Cardiology|May 14, 2003
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonanceJames C C Moon, William J McKenna, Jane A McCrohon, et al.
European Journal of Human Genetics : EJHG|January 27, 2011
Clinical utility gene card for: hypertrophic cardiomyopathy (type 1-14)Yigal M Pinto, Arthur Aam Wilde, Ingrid Aw van Rijsingen, et al.
Circulation|September 1, 2010
Myectomy plus Alfieri technique for outflow tract obstruction in hypertrophic cardiomyopathyDaniel M Sado, Andrew S Flett, Chris G A McGregor, et al.
Annals of Internal Medicine|July 20, 2005
Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical diseaseNiall G Mahon, Ross T Murphy, Calum A MacRae, et al.
Journal of Inherited Metabolic Disease|October 6, 2017
Isolated aortic root dilation in homocystinuriaMassimiliano Lorenzini, Nishan Guha, James E Davison, et al.
The American Journal of Cardiology|September 20, 2005
Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry diseaseJaymin S Shah, Derralynn A Hughes, Bhavesh Sachdev, et al.
European Heart Journal|June 7, 2006
Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathyPerry M Elliott, Juan R Gimeno, María T Tomé, et al.
The Cochrane Database of Systematic Reviews|June 23, 2025
Myosin inhibitors for treatment of hypertrophic cardiomyopathySamuel Quill, Ahmad S Amin, Folkert W Asselbergs, et al.
Pageof 30

Showing results (91-100 of 292) with videos related to

Sort By:
Pageof 30
Heart (British Cardiac Society)|January 24, 2013
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathyConstantinos O'Mahony, Maite Tome-Esteban, Pier D Lambiase, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 23, 2023
Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-makingGabrielle Norrish, Alexandros Protonotarios, Maria Stec, et al.
Journal of the American College of Cardiology|May 14, 2003
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonanceJames C C Moon, William J McKenna, Jane A McCrohon, et al.
European Journal of Human Genetics : EJHG|January 27, 2011
Clinical utility gene card for: hypertrophic cardiomyopathy (type 1-14)Yigal M Pinto, Arthur Aam Wilde, Ingrid Aw van Rijsingen, et al.
Circulation|September 1, 2010
Myectomy plus Alfieri technique for outflow tract obstruction in hypertrophic cardiomyopathyDaniel M Sado, Andrew S Flett, Chris G A McGregor, et al.
Annals of Internal Medicine|July 20, 2005
Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical diseaseNiall G Mahon, Ross T Murphy, Calum A MacRae, et al.
Journal of Inherited Metabolic Disease|October 6, 2017
Isolated aortic root dilation in homocystinuriaMassimiliano Lorenzini, Nishan Guha, James E Davison, et al.
The American Journal of Cardiology|September 20, 2005
Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry diseaseJaymin S Shah, Derralynn A Hughes, Bhavesh Sachdev, et al.
European Heart Journal|June 7, 2006
Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathyPerry M Elliott, Juan R Gimeno, María T Tomé, et al.
The Cochrane Database of Systematic Reviews|June 23, 2025
Myosin inhibitors for treatment of hypertrophic cardiomyopathySamuel Quill, Ahmad S Amin, Folkert W Asselbergs, et al.
Pageof 30